CareDx, Inc.
http://www.caredxinc.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From CareDx, Inc.
IPO Gives Kyverna Cash To Maintain Lead In Autoimmune CAR-T Development
Kyverna CEO Peter Maag spoke with Scrip about the company’s five-year overnight success after its well-received IPO. Metagenomi and Telomir also went public in the US in smaller offerings.
Minute Insight: CareDx Enters Donor Organ Procurement Market With MediGO Acquisition
MediGo extends CareDX’s digital product lineup while expanding its reach into the organ procurement organization market.
Buying The Most Time: CareDx’s Diagnostics For Transplant Recipients
An organ transplant is not a “one and done” procedure, and patients require lifelong post-operative monitoring. Medtech Insight spoke to CareDx about how monitoring could improve patient outcomes.
Deals Shaping the Medical Industry, October 2016
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in September 2016.
Company Information
- Other Names / Subsidiaries
-
- XDx, ImmuMetrix, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice